The tumour immune landscape and its implications in cutaneous melanoma-Reference-Cited by-同舟云学术

The tumour immune landscape and its implications in cutaneous melanoma

Published:2020-10 Issue:3 Volume:34 Page:529-549
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Attrill Grace H.¹²^ORCID,Ferguson Peter M.¹²³,Palendira Umaimainthan¹⁴,Long Georgina V.¹²⁵,Wilmott James S.¹²,Scolyer Richard A.¹²³

Affiliation:

1. Melanoma Institute AustraliaThe University of Sydney Sydney Australia

2. Sydney Medical School The University of Sydney Sydney Australia

3. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital and New South Wales Health Pathology Sydney Australia

4. Discipline of Infectious Diseases and Immunology School of Medical Sciences Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

5. Mater and North Shore Hospitals Sydney Australia

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.12926

Reference180 articles.

1. Neutrophils mediate antibody-induced antitumor effects in mice

2. Signatures of mutational processes in human cancer

3. Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients

4. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma

5. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

2. Contribution of Keratinocytes in Skin Cancer Initiation and Progression;International Journal of Molecular Sciences;2024-08-13

3. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07

4. Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review;Journal of Clinical Medicine;2024-08-01

5. Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients;Cancers;2024-07-26